Junfeng Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Surgery top 5%
- Pancreatic function and diabetes
- Pediatric Hepatobiliary Diseases and Treatments
Papers in
- Surgery 25
- Pediatric Hepatobiliary Diseases and Treatments 6
- Organ Transplantation Techniques and Outcomes 2
- Bladder and Urothelial Cancer Treatments 2
-
- Hedgehog Signaling Pathway Studies 4
- Co-authors
- Xueliang Zuo (5 shared papers)Juan Cai (4 shared papers)Zhiqiang Chen (4 shared papers)Jinguo Wang (4 shared papers)Beatriz Sosa‐Pineda (2 shared papers)Yao Zhang (2 shared papers)Ming Cao (1 shared paper)Xuehao Wang (1 shared paper)
- Journals
- Cochrane Database of Systematic Reviews (3 papers)Clinical and Translational Medicine (2 papers)Developmental Biology (2 papers)Anti-Cancer Agents in Medicinal Chemistry (1 paper)Medicine (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Junfeng Wang
44 papers receiving 1.3k citations
Junfeng Wang's Hit Papers
Peers
Comparison fields: 5 of 78
- Cancer Research 346
- Surgery 497
- Molecular Biology 623
- Oncology 132
- Hepatology 34
Countries citing papers authored by Junfeng Wang
This map shows the geographic impact of Junfeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Wang more than expected).
Fields of papers citing papers by Junfeng Wang
This network shows the impact of papers produced by Junfeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Wang. The network helps show where Junfeng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfeng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma Hit paper breakdown → | 2020 | 347 |
| 2 | 2003 | 132 | |
| 3 | 2005 | 114 | |
| 4 | 2019 | 92 | |
| 5 | 2015 | 82 | |
| 6 | 2019 | 78 | |
| 7 | 2022 | 65 | |
| 8 | 2019 | 40 | |
| 9 | 2017 | 40 | |
| 10 | 2022 | 37 | |
| 11 | miR-337-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells through targeting JAK2. | 2018 | 37 |
| 12 | 2013 | 33 | |
| 13 | 2019 | 27 | |
| 14 | 2020 | 24 | |
| 15 | 2020 | 23 | |
| 16 | 2019 | 12 | |
| 17 | 2013 | 11 | |
| 18 | 2018 | 10 | |
| 19 | 2023 | 10 | |
| 20 | 2017 | 10 |
About Junfeng Wang
Junfeng Wang is a scholar working on Surgery, Molecular Biology, Oncology, Cancer Research and Epidemiology, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pediatric Hepatobiliary Diseases and Treatments (6 papers), Hedgehog Signaling Pathway Studies (4 papers), Cancer-related molecular mechanisms research (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), MicroRNA in disease regulation (3 papers), Organ Transplantation Techniques and Outcomes (2 papers), Diabetes and associated disorders (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Cancer Research (346 citations), Surgery (497 citations), Molecular Biology (623 citations), Oncology (132 citations) and Hepatology (34 citations). Junfeng Wang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Xueliang Zuo, Juan Cai, Zhiqiang Chen, Jinguo Wang, Beatriz Sosa‐Pineda, Yao Zhang, Ming Cao, Xuehao Wang, Wen Gao and Jindao Wu. Their work appears in journals such as Cochrane Database of Systematic Reviews, Clinical and Translational Medicine, Developmental Biology, Anti-Cancer Agents in Medicinal Chemistry and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.